During the past decade, People's Hospital of Quzhou conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "People's Hospital of Quzhou" are "Nasopharyngeal Carcinoma" (2 trials) and "Neoadjuvant Chemotherapy" (1 trials). Many other conditions were trialed in "People's Hospital of Quzhou" in a lesser frequency.

Most popular intervention types in "People's Hospital of Quzhou" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy" (1 trials), "4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy" (1 trials) and "Endostatin and Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "People's Hospital of Quzhou" are 2 trials for "All" genders.

Currently, there are NaN active trials in "People's Hospital of Quzhou". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in People's Hospital of Quzhou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in People's Hospital of Quzhou, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".